F2 and deep vein thrombosis: Among recipients, factor V Leiden or prothrombin G20210A mutation were found in 5 cases (19.2%) and 4 controls (5.1%) and carriers had a 4-fold increased risk of thrombosis, that increased to 6.5-fold when only venous thrombosis was considered (Table 4).